BP000268-CHM-255: Recombinant Mouse GROγ (CXCL3)
Source: E. coli-derived.
Determined by its ability to chemoattract 293 transfected CXCR2 cells using a concentration range of 10-100 ug/ml, corresponding to a specific activity of 10,000-100,000 units/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000268-CHM-258: Recombinant Rat GROγ (CXCL3), CINC-2 alpha
Source: E. coli-derived.
Determined by its ability to chemoattract 293 transfected CXCR2 cells using a concentration range of 10-100 ug/ml, corresponding to a specific activity of 10,000-100,000 units/mg.
Purity > 98%, by SDS-PAGE and RP-HPLC.BP000268-CHM-273: Recombinant Rat GROγ (CXCL3), CINC-2 beta
Source: E. coli-derived.
Determined by its ability to chemoattract human CXCR2 transfected 293 cells using a concentration range of 10-100 ug/ml.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000268-CHM-283: Recombinant Mouse GROγ (CXCL3), His Tag
Source: E. coli-derived.
Purity > 90%, by SDS-PAGE.BP000268-CHM-310: Recombinant Human GROγ (CXCL3)
Source: E. coli-derived.
The Biological activity is calculated by its ability to chemoattract CXCR2 transfected 293 cells using 10-100 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity > 98%, by SDS-PAGE and RP-HPLC.BP000269-CHM-002: Recombinant Mouse GRO1/KC (CXCL1), His Tag
Source: E. coli-derived.
Purity > 90%, by SDS-PAGE.BP000269-CHM-335: Recombinant Mouse GRO1/KC (CXCL1)
Source: E. coli-derived.
The biological activity was determined by measuring the dose dependent mobilization of intracellular calcium (calcium flux) with human neutrophils. Significant calcium mobilization is observed with 50 ug/ml of recombinant mouse KC (Specific Activity: 2 x 10000 units/mg).
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000270-CHM-376: Recombinant MIP-2 Viral
Source: E. coli-derived.
Determined by the inhibitory effect on monocyte migration response to human MIP1A using a concentration range of 1 ug/ml-10 ug/ml of viral MIP2 which will inhibit 25 ug/ml of human MIP1A.
Purity > 97%, by RP-HPLC and SDS-PAGE.BP000271-CHM-231: Recombinant Human Interleukin-8 (IL-8) Protein
Source: E. coli-derived.
Specific Activity of IL8 in chemotaxis of donor PBL neutrophils, threshold concentration corresponding to 10-100 ug/ml corresponding to a Specific Activity of 1,000-10,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000271-CHM-327: Recombinant Human Interleukin-8 (IL-8) Protein
Source: E. coli-derived.
Specific Activity of IL8 in chemotaxis of donor PBL neutrophils, threshold concentration corresponding to 25-150 ug/ml corresponding to a Specific Activity of 6,667-40,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.